Category: Fertility Law - Page 20

Filter by category

29
Jul
2021

Human genome editing in a fertility context: The World Health Organization’s framework for governance of human genome editing

People regularly ask what genomics has got to do with fertility (beyond genetic testing of embryos) and assisted reproduction law and policy. They are often puzzled about the link between genomic technology and fertility and why this is something they should think about or concern themselves with, instead equating gene editing technology with scientists in laboratories and pharmaceutical trials focused on curing cancer and conditions like sickle-cell and Huntington’s disease.

01
Jul
2021

IVF rights in France to be extended to single women and lesbian couples

This week (29 June 2021), the French parliament passed a bill which will give single women and lesbian couples the right to access fertility treatment in France. Up until now, restrictive laws have meant that only heterosexual couples have been eligible to undergo fertility treatment, such as IVF, in France. This left single women and lesbian couples having to travel abroad for fertility treatment. As such, this new legislation means that for the first time in France all women under 43 will be able to access fertility treatment regardless of sexual orientation or relationship status.

16
Jun
2021

UK fertility treatment trends over the last 30 years

The Human Fertilisation and Embryology Authority (‘HFEA’) published its latest statistics and analysis of fertility treatment trends in the UK las month (May 2021). This coincided with the HFEA’s 30th anniversary following its introduction in 1991. It paints a largely positive picture prior to the Covid-19 pandemic, showing marked increases in fertility treatment success rates over the last 30 years. Overall, since 1991 approximately 1.3 million IVF cycles and more than 260,000 DI cycles have been undertaken in the UK, resulting in the birth of 390,000 babies. This represents a significant achievement.

22
May
2021

Why we need genomic and fertility law reform part V

Covid-19 is an effective mass disrupter with serious global morbidity and mortality implications. It is, however, just part of a wider complex picture that is rapidly evolving around us. With the continual development of powerful transformative gene-editing tools and scientific and digital technology we increasingly have the capacity to digitally programme, enhance and re-structure our genome and life itself. There is therefore an urgent need to implement intelligent genomic and fertility law reform and develop new policies and practices to deal with fallout from the Covid-19 global pandemic, changing geopolitics, evolving biopolitics, declining fertility levels and rapid intersection of genomics, digital, AI and assisted reproductive technology.

In the News

X updates

Follow Louisa on X for latest industry updates

Articles & Publications

The latest news on fertility and modern family law

News & Commentary

Louisa discusses her opinion on different topics